• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测 COVID-19 疾病严重程度的新型评分系统。

A Novel Scoring System for Prediction of Disease Severity in COVID-19.

机构信息

Beijing You'an Hospital, Capital Medical University, Beijing, China.

Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford, Oxford, United Kingdom.

出版信息

Front Cell Infect Microbiol. 2020 Jun 5;10:318. doi: 10.3389/fcimb.2020.00318. eCollection 2020.

DOI:10.3389/fcimb.2020.00318
PMID:32582575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7292148/
Abstract

A novel enveloped RNA beta coronavirus, Corona Virus Disease 2019 (COVID-19) caused severe and even fetal pneumonia in China and other countries from December 2019. Early detection of severe patients with COVID-19 is of great significance to shorten the disease course and reduce mortality. We assembled a retrospective cohort of 80 patients (including 56 mild and 24 severe) with COVID-19 infection treated at Beijing You'an Hospital. We used univariable and multivariable logistic regression analyses to select the risk factors of severe and even fetal pneumonia and build scoring system for prediction, which was validated later on in a group of 22 COVID-19 patients. Age, white blood cell count, neutrophil, glomerular filtration rate, and myoglobin were selected by multivariate analysis as candidates of scoring system for prediction of disease severity in COVID-19. The scoring system was applied to calculate the predictive value and found that the percentage of ICU admission (20%, 6/30) and ventilation (16.7%, 5/30) in patients with high risk was much higher than those (2%, 1/50; 2%, 1/50) in patients with low risk ( = 0.009; = 0.026). The AUC of scoring system was 0.906, sensitivity of prediction is 70.8%, and the specificity is 89.3%. According to scoring system, the probability of patients in high risk group developing severe disease was 20.24 times than that in low risk group. The possibility of severity in COVID-19 infection predicted by scoring system could help patients to receiving different therapy strategies at a very early stage. COVID-19, severe and fetal pneumonia, logistic regression, scoring system, prediction.

摘要

一种新型包膜 RNA β 冠状病毒,即 2019 年冠状病毒病(COVID-19),自 2019 年 12 月以来在中国和其他国家引发了严重甚至胎儿肺炎。早期发现 COVID-19 重症患者对于缩短病程和降低死亡率具有重要意义。我们回顾性收集了北京佑安医院收治的 80 例 COVID-19 感染患者(包括 56 例轻症和 24 例重症)的临床资料。我们采用单因素和多因素逻辑回归分析筛选 COVID-19 重症及胎儿肺炎的危险因素,并建立预测评分系统,随后在 22 例 COVID-19 患者中进行验证。多因素分析选择年龄、白细胞计数、中性粒细胞、肾小球滤过率和肌红蛋白作为预测 COVID-19 疾病严重程度评分系统的候选因素。评分系统用于计算预测价值,发现高危患者的 ICU 入住率(20%,6/30)和通气率(16.7%,5/30)明显高于低危患者(2%,1/50;2%,1/50;=0.009;=0.026)。评分系统的 AUC 为 0.906,预测的敏感度为 70.8%,特异性为 89.3%。根据评分系统,高危组患者发生重症疾病的概率是低危组的 20.24 倍。评分系统预测 COVID-19 感染严重程度的可能性有助于患者在早期接受不同的治疗策略。COVID-19,重症和胎儿肺炎,逻辑回归,评分系统,预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/7292148/808b53d3eefb/fcimb-10-00318-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/7292148/808b53d3eefb/fcimb-10-00318-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/7292148/808b53d3eefb/fcimb-10-00318-g0001.jpg

相似文献

1
A Novel Scoring System for Prediction of Disease Severity in COVID-19.一种用于预测 COVID-19 疾病严重程度的新型评分系统。
Front Cell Infect Microbiol. 2020 Jun 5;10:318. doi: 10.3389/fcimb.2020.00318. eCollection 2020.
2
Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.利用 IL-2R/淋巴细胞预测 COVID-19 患者的临床进展。
Clin Exp Immunol. 2020 Jul;201(1):76-84. doi: 10.1111/cei.13450. Epub 2020 May 15.
3
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
4
Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.HNC-LL 评分预测 2019 年冠状病毒病严重程度的开发和验证。
EBioMedicine. 2020 Jul;57:102880. doi: 10.1016/j.ebiom.2020.102880. Epub 2020 Jul 7.
5
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.中国武汉癌症患者 COVID-19 疾病严重程度相关的临床特征和危险因素:一项多中心、回顾性、队列研究。
Lancet Oncol. 2020 Jul;21(7):893-903. doi: 10.1016/S1470-2045(20)30309-0. Epub 2020 May 29.
6
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.血细胞计数作为预测 COVID-19 疾病进展的潜在生物标志物:一项回顾性研究。
Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377.
7
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.白细胞增多和淋巴细胞减少对冠状病毒疾病严重程度的预后价值。
Emerg Infect Dis. 2020 Aug;26(8):1839-1841. doi: 10.3201/eid2608.201160. Epub 2020 May 8.
8
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.COVID-19 不同于 SARS-CoV-2 阴性社区获得性肺炎。
Front Cell Infect Microbiol. 2020 Jun 16;10:322. doi: 10.3389/fcimb.2020.00322. eCollection 2020.
9
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.
10
C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.C 反应蛋白与计算机断层扫描结果相关,可早期预测严重 COVID-19。
J Med Virol. 2020 Jul;92(7):856-862. doi: 10.1002/jmv.25871. Epub 2020 Apr 25.

引用本文的文献

1
Neutrophil-to-Lymphocyte Ratio and Cytokine Profiling as Predictors of Disease Severity and Survival in Unvaccinated COVID-19 Patients.中性粒细胞与淋巴细胞比值及细胞因子谱作为未接种疫苗的COVID-19患者疾病严重程度和生存的预测指标
Vaccines (Basel). 2024 Jul 31;12(8):861. doi: 10.3390/vaccines12080861.
2
A Correlation Study to Comprehend the SAR-CoV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of As sam, Northeast India.一项相关性研究旨在理解在印度东北部阿萨姆邦卡姆鲁普区接种疫苗人群中的 SARS-CoV-2 病毒载量、抗病毒抗体滴度以及感染后 COVID-19 症状的严重程度之间的关系。
Endocr Metab Immune Disord Drug Targets. 2024;24(12):1414-1421. doi: 10.2174/0118715303281124231213110004.
3

本文引用的文献

1
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
2
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
3
A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.
Taming the SARS-CoV-2-mediated proinflammatory response with BromAc.用 BromAc 抑制 SARS-CoV-2 介导的促炎反应
Front Immunol. 2023 Dec 13;14:1308477. doi: 10.3389/fimmu.2023.1308477. eCollection 2023.
4
Machine learning-based prediction of COVID-19 mortality using immunological and metabolic biomarkers.使用免疫和代谢生物标志物基于机器学习预测COVID-19死亡率
BMC Digit Health. 2023;1(1):6. doi: 10.1186/s44247-022-00001-0. Epub 2023 Feb 3.
5
Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile.智利住院COVID-19患者队列中CALL评分作为死亡率预测工具的验证
Front Med (Lausanne). 2023 Aug 28;10:1164615. doi: 10.3389/fmed.2023.1164615. eCollection 2023.
6
Sociodemographic, clinical and laboratory characteristics and risk factors for mortality of hospitalized COVID-19 patients at alternate care site: a Latin American experience.拉丁美洲经验:在替代护理场所住院的 COVID-19 患者的人口统计学、临床和实验室特征以及死亡风险因素。
Ann Med. 2023 Dec;55(1):2224049. doi: 10.1080/07853890.2023.2224049.
7
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission.对 COVID-19 患者免疫细胞的多维分析确定了与入院时严重程度相关的细胞亚群。
PLoS Pathog. 2023 Jun 13;19(6):e1011432. doi: 10.1371/journal.ppat.1011432. eCollection 2023 Jun.
8
Face mask ownership/utilisation and COVID-19 vaccine hesitancy amongst patients recovering from COVID-19 in Cameroon: A cross-sectional study.《喀麦隆 COVID-19 康复患者的口罩拥有/使用情况与 COVID-19 疫苗犹豫:一项横断面研究》。
PLoS One. 2023 Jan 20;18(1):e0280269. doi: 10.1371/journal.pone.0280269. eCollection 2023.
9
The use of prognostic nutritional index (PNI) and selected inflammatory indicators for predicting malnutrition in COVID-19 patients: A retrospective study.运用预后营养指数(PNI)和特定炎症指标预测 COVID-19 患者的营养不良:一项回顾性研究。
J Infect Public Health. 2023 Feb;16(2):280-285. doi: 10.1016/j.jiph.2022.12.018. Epub 2022 Dec 30.
10
A novel scoring system for early assessment of the risk of the COVID-19-associated mortality in hospitalized patients: COVID-19 BURDEN.一种用于评估住院患者 COVID-19 相关死亡率风险的新型评分系统:COVID-19 负担。
Eur J Med Res. 2023 Jan 3;28(1):4. doi: 10.1186/s40001-022-00908-4.
一种用于早期预测严重 2019 冠状病毒病(COVID-19)的工具:来自中国武汉和广东的多中心研究使用风险列线图。
Clin Infect Dis. 2020 Jul 28;71(15):833-840. doi: 10.1093/cid/ciaa443.
4
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
5
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.淋巴细胞亚群(CD4+、CD8+)计数反映感染的严重程度,并可预测新型冠状病毒肺炎患者的临床结局。
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.054. Epub 2020 Apr 11.
6
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
7
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素:基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.